Chronic pelvic pain affects 2.1% to 24% of the global female population,12 and up to half of the affected women have no obvious pathology.23 The neuromodulator gabapentin can be used to modulate pain, but the evidence for its effectiveness and safety is limited, as discussed by Andrew Horne and colleagues in a related article (doi:10.1136/bmj.j3520) . Here, James Duffy explores how we should manage women with unexplained chronic pain in light of this uncertainty. Treatment of women with chronic pelvic pain is directed towards achievement of higher function with some pain rather than a cure.4 At the initial consultation, explore and document the severity of …

中文翻译：

---

鉴于对加巴喷丁有效性的不确定性，我们应该如何管理患有无法解释的慢性盆腔疼痛的女性？

慢性盆腔疼痛影响全球 2.1% 至 24% 的女性人口，12 多达一半的受影响女性没有明显的病理变化。 23 神经调节剂加巴喷丁可用于调节疼痛，但其有效性和安全性的证据有限，正如 Andrew Horne 及其同事在相关文章 (doi:10.1136/bmj.j3520) 中所讨论的。在这里，James Duffy 探讨了鉴于这种不确定性，我们应该如何管理患有无法解释的慢性疼痛的女性。对患有慢性盆腔疼痛的女性的治疗旨在通过一些疼痛而不是治愈来实现更高的功能。4 在最初的咨询中，探索并记录......